HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Giaisi Selected Research

Kaposi Sarcoma (Kaposi's Sarcoma)

8/2007Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Giaisi Research Topics

Disease

12Neoplasms (Cancer)
01/2017 - 12/2006
4Leukemia
01/2017 - 12/2006
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2017 - 08/2012
3Inflammation (Inflammations)
01/2010 - 09/2002
2Thrombocytopenia (Thrombopenia)
01/2016 - 02/2015
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2016 - 05/2006
2T-Cell Leukemia (Leukemia, T Cell)
02/2015 - 02/2008
2Lymphoma (Lymphomas)
02/2015 - 08/2012
1Multiple Myeloma
01/2017
1Neoplasm Metastasis (Metastasis)
08/2016
1Lymphoid Leukemia
02/2015
1Wilms Tumor (Wilm's Tumor)
01/2014
1Hodgkin Disease (Hodgkin's Disease)
08/2012
1Colonic Neoplasms (Colon Cancer)
01/2012
1Breast Neoplasms (Breast Cancer)
01/2012
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Melanoma (Melanoma, Malignant)
01/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2012
1Hematologic Neoplasms (Hematological Malignancy)
02/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2007
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2007
1Kaposi Sarcoma (Kaposi's Sarcoma)
08/2007
1Asthma (Bronchial Asthma)
06/2005
1Skin Diseases (Skin Disease)
06/2005
1Hypersensitivity (Allergy)
09/2002

Drug/Important Bio-Agent (IBA)

5rocaglamideIBA
01/2017 - 10/2007
4wogoninIBA
02/2015 - 12/2006
3Proteins (Proteins, Gene)FDA Link
04/2014 - 05/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2012 - 12/2006
2navitoclaxIBA
01/2016 - 02/2015
2chrysinIBA
02/2015 - 01/2012
2ApigeninIBA
02/2015 - 01/2012
2FlavonesIBA
02/2015 - 01/2012
2LigandsIBA
08/2012 - 01/2012
2Antineoplastic Agents (Antineoplastics)IBA
08/2012 - 01/2012
2Interleukin-4 (Interleukin 4)IBA
01/2010 - 09/2002
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2017
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
08/2016
1PhytochemicalsIBA
08/2016
1antineoplaston A10 (A 10)IBA
01/2016
1DiterpenesIBA
12/2015
1LuteolinIBA
02/2015
1baicaleinIBA
02/2015
1venetoclaxIBA
02/2015
1Apoptosis Regulatory ProteinsIBA
02/2015
1Messenger RNA (mRNA)IBA
01/2014
1WT1 ProteinsIBA
01/2014
1Fas Ligand Protein (Fas Ligand)IBA
01/2014
1TNF-Related Apoptosis-Inducing LigandIBA
01/2012
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2012
1CytokinesIBA
01/2010
1Mitogen-Activated Protein KinasesIBA
10/2007
1p38 Mitogen-Activated Protein KinasesIBA
10/2007
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2007
1Antimalarials (Antimalarial Agents)IBA
08/2007
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2007
1ArtesunateIBA
08/2007
1Cycloheximide (Cicloheximide)IBA
12/2006
1Protein Synthesis InhibitorsIBA
12/2006
1Free RadicalsIBA
12/2006
1Dactinomycin (Actinomycin)FDA LinkGeneric
12/2006
1NF-kappa B (NF-kB)IBA
12/2006
1Trans-Activators (Trans-Acting Factor)IBA
05/2006
1parthenolideIBA
12/2002
1IgE Receptors (Fc epsilon RI)IBA
09/2002
1Vitamin EFDA LinkGeneric
09/2002
1Immunoglobulin E (IgE)IBA
09/2002

Therapy/Procedure

5Drug Therapy (Chemotherapy)
08/2016 - 08/2007
4Therapeutics
01/2017 - 02/2015
1Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2008
1Traditional Medicine (Folk Remedies)
06/2005